Does Amphotericin B (antifungal medication) need to be diluted before injection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amphotericin B Must Be Diluted Before Intravenous Administration

Yes, amphotericin B injection absolutely requires dilution before administration—this is a non-negotiable requirement for safe intravenous use. The lyophilized powder must first be reconstituted with sterile water, then further diluted in 5% dextrose solution before infusion 1.

Reconstitution and Dilution Protocol

Initial Reconstitution

  • Reconstitute the lyophilized cake by adding 10 mL of Sterile Water for Injection (without bacteriostatic agents) directly to the vial to create an initial concentrate of 5 mg/mL 1
  • Use a sterile needle with minimum 20-gauge diameter and shake immediately until the colloidal solution is clear 1
  • This concentrated solution cannot be administered directly and requires further dilution 1

Final Dilution for Infusion

  • The reconstituted concentrate must be further diluted 1:50 with 5% Dextrose Injection to achieve a final concentration of 0.1 mg/mL (1 mg per 10 mL) 1
  • The pH of the dextrose solution must be above 4.2 before use; if below 4.2, add 1-2 mL of phosphate buffer 1
  • Alternative concentrations of 0.25-1.4 mg/mL in 5% dextrose can be used depending on clinical needs 2

Critical Safety Considerations

What NOT to Use

  • Never reconstitute or dilute with saline solutions—this will cause precipitation of the drug 1
  • Do not use any diluent containing bacteriostatic agents (e.g., benzyl alcohol) as this causes precipitation 1
  • Avoid any dextrose solution with pH below 4.2 unless buffered appropriately 1

Aseptic Technique Requirements

  • Strict aseptic technique is mandatory throughout preparation since no preservative is present 1
  • All entries into vials or diluents must use sterile needles 1
  • Discard any solution showing evidence of precipitation or foreign matter 1

Administration Parameters

Infusion Rate and Duration

  • Infuse over 2-6 hours for conventional amphotericin B deoxycholate, with typical infusions lasting 1-2 hours in patients with adequate renal function 3, 1
  • Infusion rate should not exceed 50 mg/hour 2
  • Liposomal formulations typically infuse over 2 hours (minimum 1 hour) 3
  • Patients with azotemia or hyperkalemia require longer infusion times of 3-6 hours to reduce toxicity 4

Pre-medication and Hydration

  • Administer 1 L of normal saline 30 minutes before amphotericin B infusion to reduce nephrotoxicity in patients who can tolerate fluids 5, 4
  • Pre-medicate with diphenhydramine or acetaminophen to reduce infusion-related reactions (fever, chills, rigors) 5, 3
  • Consider prophylactic meperidine for patients with history of severe rigors 6

Filtration Considerations

  • An in-line membrane filter may be used during infusion, but the mean pore diameter must not be less than 1.0 micron to ensure passage of the colloidal dispersion 1

Storage of Diluted Solutions

  • Admixtures of amphotericin B 0.25 mg/mL in 5% dextrose have a 35-day expiration when stored at 4-8°C 2
  • Higher concentrations (1.4 mg/mL) have only 36-hour stability 2
  • Protection from fluorescent light is unnecessary 2
  • Store in polyolefin, glass, or polyvinyl chloride containers; avoid evacuated containers with buffers 2

Common Pitfalls to Avoid

  • Using saline as a diluent is the most common error and results in immediate precipitation 1
  • Failing to check dextrose pH before dilution can lead to drug precipitation 1
  • Administering the initial 5 mg/mL concentrate without further dilution causes severe toxicity 1
  • Using filters with pore size less than 1.0 micron blocks drug passage 1

References

Research

Practical guidelines for preparing and administering amphotericin B.

American journal of hospital pharmacy, 1992

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Mechanism of Amphotericin B-Induced Hypokalemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Administration Protocol for Lyophilized Amphotericin B

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.